Literature DB >> 20723298

[Effect of arsenic trioxide on induction of apoptosis in MCL cell line and its possible mechanisms].

Ai-Mei Fei1, Chao-Ming Mao, Jing-Jing Liu, Jiang Zhu, Jian-Qing Mi.   

Abstract

This study was aimed to explore the effect of arsenic trioxide (ATO) on proliferation and apoptosis of mantle cell lymphoma (MCL) cell lines and the underlying mechanisms of the apoptosis. MCL cell lines (jeko-1, mino, JVM-2) were treated with different concentrations of ATO, then growth profile of these cells were detected by MTT. Apoptosis of ATO-treated jeko-1 cells were detected by flow cytometry with Annexin V-FITC/PI double staining. The loss of mitochondrial membrane potential of ATO-treated jeko-1 cells were detected by FCM with DiOC₆(3) staining. The expressions of cyclin D1 and apoptosis related proteins MCL-1, BCL-2, PUMA, NOXA, cCaspase-3 (cleaved caspase-3), cCaspase-9 (cleaved caspase-9), cPARP (cleaved PARP) were detected by Western blot. The results indicated that ATO inhibited cell growth, induced apoptosis of MCL cells and disrupted mitochondrial membrane potential. ATO could decrease expressions of MCL-1, PUMA and cyclin D1, increase expressions of cPARP, cCaspase-3, cCaspase-9 and the expressions of BLC-2 and NOXA were not changed. It is concluded that ATO can induce cell growth arrest and apoptosis of MCL cells. The mitochondrial pathway plays a very important role in cell apoptosis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20723298

Source DB:  PubMed          Journal:  Zhongguo Shi Yan Xue Ye Xue Za Zhi        ISSN: 1009-2137


  2 in total

1.  Synergistic anticancer effects of arsenic trioxide with bortezomib in mantle cell lymphoma.

Authors:  Hyun Joo Jung; Zheng Chen; Nami McCarty
Journal:  Am J Hematol       Date:  2012-09-11       Impact factor: 10.047

2.  Arsenic trioxide rewires mantle cell lymphoma response to bortezomib.

Authors:  Ling-Ling Zhao; Yuan-Fang Liu; Li-Jun Peng; Ai-Mei Fei; Wen Cui; Sheng-Chao Miao; Olivier Hermine; Remy Gressin; Saadi Khochbin; Sai-Juan Chen; Jin Wang; Jian-Qing Mi
Journal:  Cancer Med       Date:  2015-08-26       Impact factor: 4.452

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.